Bayer Schering Pharma AG, Germany, has received approval from The U.S. entity of Food and Drug Administration (FDA) for its new Natazia® (estradiol valerate/ dienogest) pill for the prevention of pregnancy.

As any do-it-yourselfer knows, a good home improvement project has both style and substance, adding functionality with aesthetic appeal. For people with rheumatoid arthritis (RA) who may face difficulties around the house, adaptable options around the home are particularly important.

In a clinical study Boehringer Ingelheim recently conducted, Dulcolax® tablets with the active ingredient bisacodyl clearly demonstrated efficacy by increasing the frequency and regularity of bowel movements.

GlaxoSmithKline (GSK) entered into a strategic alliance with Dong-A Pharmaceuticals Co., Ltd. (Dong-A), the number one pharmaceutical and OTC Company in South Korea.

Merck & Co., Inc. (NYSE: MRK) hosted its first R&D and Business Briefing since completion of the Merck and Schering-Plough merger and outlined the company's strategy to drive global business growth.

Further strengthening its global competitive position, Abbott (NYSE: ABT) announced a licensing and supply agreement with Zydus Cadila of India for a portfolio of pharmaceutical products that Abbott will commercialize in 15 emerging markets, enabling the company to further accelerate its emerging markets growth.

GlaxoSmithKline (NYSE: GSK) participated in a U.S. Food and Drug Administration (FDA) advisory committee meeting convened to discuss recent findings of porcine circovirus (PCV) in rotavirus vaccines.